Terms: = Germ cell tumor AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Diagnosis
33 results:
1. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
[TBL] [Abstract] [Full Text] [Related]
2. sil-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
Barak V; Kalickman I; Pe'er J
Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
[TBL] [Abstract] [Full Text] [Related]
3. Malignant Melanoma: Skin Cancer-diagnosis, Prevention, and Treatment.
Ahmed B; Qadir MI; Ghafoor S
Crit Rev Eukaryot Gene Expr; 2020; 30(4):291-297. PubMed ID: 32894659
[TBL] [Abstract] [Full Text] [Related]
4. Lifestyle among long-term survivors of cancers in young adulthood.
Bøhn SH; Lie HC; Reinertsen KV; Fosså SD; Haugnes HS; Kiserud CE; Loge JH; Wisløff T; Thorsen L
Support Care Cancer; 2021 Jan; 29(1):289-300. PubMed ID: 32358776
[TBL] [Abstract] [Full Text] [Related]
5. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ladenstein R; Pötschger U; Valteau-Couanet D; Luksch R; Castel V; Yaniv I; Laureys G; Brock P; Michon JM; Owens C; Trahair T; Chan GCF; Ruud E; Schroeder H; Beck Popovic M; Schreier G; Loibner H; Ambros P; Holmes K; Castellani MR; Gaze MN; Garaventa A; Pearson ADJ; Lode HN
Lancet Oncol; 2018 Dec; 19(12):1617-1629. PubMed ID: 30442501
[TBL] [Abstract] [Full Text] [Related]
6. Vogt-Koyanagi-Harada-like Syndrome Complicating Pembrolizumab Treatment for Metastatic Melanoma.
Bricout M; Petre A; Amini-Adle M; Bezza W; Seve P; Kodjikian L; Dalle S; Thomas L
J Immunother; 2017; 40(2):77-82. PubMed ID: 28166182
[TBL] [Abstract] [Full Text] [Related]
7. The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease.
Baugh J; Bartels U; Leach J; Jones B; Chaney B; Warren KE; Kirkendall J; Doughman R; Hawkins C; Miles L; Fuller C; Hassall T; Bouffet E; Lane A; Hargrave D; Grill J; Hoffman LM; Jones C; Towbin A; Savage SA; Monje M; Li XN; Ziegler DS; Veldhuijzen van Zanten S; Kramm CM; van Vuurden DG; Fouladi M
J Neurooncol; 2017 Apr; 132(2):323-331. PubMed ID: 28093680
[TBL] [Abstract] [Full Text] [Related]
8. Evidence for the efficacy of immunotherapy in children with high-risk neuroblastoma.
Szychot E; Peregud-Pogorzelski J; Wawryków P; Brodkiewicz A
Postepy Hig Med Dosw (Online); 2016 Sep; 70(0):1001-1004. PubMed ID: 27708204
[TBL] [Abstract] [Full Text] [Related]
9. Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation.
Tseng J; Citrin DE; Waldman M; White DE; Rosenberg SA; Yang JC
Cancer; 2014 May; 120(9):1426-32. PubMed ID: 24474396
[TBL] [Abstract] [Full Text] [Related]
10. Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.
Avril T; Vauleon E; Hamlat A; Saikali S; Etcheverry A; Delmas C; Diabira S; Mosser J; Quillien V
Brain Pathol; 2012 Mar; 22(2):159-74. PubMed ID: 21790828
[TBL] [Abstract] [Full Text] [Related]
11. Cytokines in neuroblastoma: from pathogenesis to treatment.
Pistoia V; Bianchi G; Borgonovo G; Raffaghello L
Immunotherapy; 2011 Jul; 3(7):895-907. PubMed ID: 21751957
[TBL] [Abstract] [Full Text] [Related]
12. Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma.
Thavendiranathan P; Verhaert D; Kendra KL; Raman SV
Br J Radiol; 2011 May; 84(1001):e99-e102. PubMed ID: 21511746
[TBL] [Abstract] [Full Text] [Related]
13. Bromohydrin pyrophosphate-stimulated Vgamma9delta2 T cells expanded ex vivo from patients with poor-prognosis neuroblastoma lyse autologous primary tumor cells.
Chargui J; Combaret V; Scaglione V; Iacono I; Péri V; Valteau-Couanet D; Dubrel M; Angevin E; Puisieux A; Romagne F; Bergeron C
J Immunother; 2010; 33(6):591-8. PubMed ID: 20551838
[TBL] [Abstract] [Full Text] [Related]
14. il-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs).
Berković MC; Jokić M; Marout J; Radosević S; Zjacić-Rotkvić V; Kapitanović S
J Mol Med (Berl); 2010 Apr; 88(4):423-9. PubMed ID: 20049409
[TBL] [Abstract] [Full Text] [Related]
15. Immunogenicity of human neuroblastoma.
Prigione I; Corrias MV; Airoldi I; Raffaghello L; Morandi F; Bocca P; Cocco C; Ferrone S; Pistoia V
Ann N Y Acad Sci; 2004 Dec; 1028():69-80. PubMed ID: 15650233
[TBL] [Abstract] [Full Text] [Related]
16. Long-term results of high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma patients: a report of the Spanish working party for BMT in children (Getmon).
Verdeguer A; Muñoz A; Cañete A; Pardo N; Martínez A; Donat J; Gómez P; Bureo E; Fernández JM; Cubells J; Maldonado M; Sastre A
Pediatr Hematol Oncol; 2004 Sep; 21(6):495-504. PubMed ID: 15552813
[TBL] [Abstract] [Full Text] [Related]
17. Case report and brief review: il-2-induced myocarditis.
Eisner RM; Husain A; Clark JI
Cancer Invest; 2004; 22(3):401-4. PubMed ID: 15493361
[TBL] [Abstract] [Full Text] [Related]
18. Gastrointestinal perforations associated with interleukin-2 administration.
Heimann DM; Schwartzentruber DJ
J Immunother; 2004; 27(3):254-8. PubMed ID: 15076143
[TBL] [Abstract] [Full Text] [Related]
19. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (il-2 and IL-12) in lung cancers.
Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M
Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151
[TBL] [Abstract] [Full Text] [Related]
20. Does continuous-infusion interleukin-2 increase survival in metastatic melanoma?
Dillman RO; O'Connor AA; Simpson L; Barth NM; VanderMolen LA; Vanderplas P
Am J Clin Oncol; 2003 Apr; 26(2):141-5. PubMed ID: 12714884
[TBL] [Abstract] [Full Text] [Related]
[Next]
